NCT04199806撤回不适用
Retrospective Study of Patient Surveys of MMS Experience
Zeltiq Aesthetics0 个研究点开始时间: 2019年11月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 主要终点
- Efficacy Endpoint: Overall Experience Questionnaire
研究概览
简要总结
To collect data from Allergan Patient Surveys (patient surveys) and Allergan Patient Information Form (patient information form) to describe:
- Patient demographics
- Treatment patterns
- Patient feedback and overall experience with MMS treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subject has received MMS treatment in the abdomen and/or buttocks (with CoolTone prototype)
- •Subject has completed the Allergan patient survey and information form on MMS experience between July 1, 2019 and December 1, 2019.
排除标准
- •There are no exclusion criteria for this study.
结局指标
主要结局
Efficacy Endpoint: Overall Experience Questionnaire
时间窗: Immediately post subjects final treatment.
Evaluation of patient overall experience with MMS treatment as measured by patient survey.
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Subchondroplasty Procedure in Patients With Bone Marrow LesionsBone Marrow LesionsBone Marrow EdemaNCT03430219Zimmer Biomet93
已完成
不适用
Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APSOsteoarthritis, KneeNCT02580643Zimmer Biomet78
已完成
不适用
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 TherapiesClinically Isolated SyndromeRelapsing Multiple SclerosisRelapsing-remitting Multiple SclerosisSecondary Progressive Multiple SclerosisNCT06526000Novartis326
招募中
不适用
xPedite: A Study to Expedite DIPG and DMG ResearchOncologyDIPGDMGNCT06140719xCures400
已完成
不适用
An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With MitoxantroneRelapsing-Remitting Multiple SclerosisNCT01142518Merck KGaA, Darmstadt, Germany86